|
Description:
|
|
In this special WCLC 2024 episode of Lung Cancer Considered, host Dr. Narjust Florez discusses daily highlights from the conference.
Dr. Xiuning Le reports updated results of BAY 292708, and Dr. Gerrina Ruiter summarizes the Beamion LUNG-1 study, both of which evaluate the efficacy of therapies for patients with HER2-Mutant NSCLC. Dr. Fiona Hegi-Johnson adds her perspective as a discussant of the POLESTAR trial evaluating EGFR therapy after chemoradiation in stage III unresectable NSCLC.
Guests:
Dr. Fiona Hegi-Johnson
Radiation Oncologist at the Peter MacCallum Cancer Centre
Senior Research Fellow at the University of Melbourne
Dr. Xiuning Le, M.D., Ph.D.
Assistant Professor in the Department of Thoracic/Head and Neck Medical Oncology
University of Texas M.D. Anderson Cancer Center
Dr. Gerrina Ruiter, M.D., Ph.D.
Pulmonologist Specialized in Thoracic Oncology at the Netherlands Cancer Institute
Amsterdam, The Netherlands |
.png)
More
Religion & Spirituality
Education
Arts and Design
Health
Fashion & Beauty
Government & Organizations
Kids & family
Music
News & Politics
Science & Medicine
Society & Culture
Sports & Recreation
TV & Film
Technology
Philosophy
Storytelling
Horror and Paranomal
True Crime
Leisure
Travel
Fiction
Crypto
Marketing
History
Comedy
Arts
Games & Hobbies
Business
Motivation